Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2-3-10 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan.
Analyst. 2019 May 28;144(11):3483-3487. doi: 10.1039/c8an02240b.
A redox-sensitive inter-conversion between ascorbic acid (ASC) and its oxidized form dehydroascorbic acid (DHA) in the intracellular environment has been of exceptional interest to recent metabolomics and pharmaceutical research. We developed a chromatographic protocol to instantly determine these vitamers with each identity from cellular extracts, without any labeling and pretreatments. Owing to its simplicity, one can readily continue the assay for hours, an otherwise difficult to cover timescale at which the intracellular DHA-ASC conversion comes into play. The method was validated for the analysis of pancreatic cancer cells, to our knowledge the first-ever study on a nucleated cell type, to trace in detail their kinetics of glucose transporter-dependent DHA uptake and, simultaneously, that for the intracellular ASC conversion. The simplest of all the relevant techniques and yet with the unique ability to provide each vitamer identity on a high-throughput basis, this method should offer the most practical option for VC-involved physiological and pharmaceutical studies including high-dose VC cancer therapy.
细胞内环境中抗坏血酸(ASC)与其氧化形式脱氢抗坏血酸(DHA)之间的氧化还原敏感互变一直是最近代谢组学和药物研究的热点。我们开发了一种色谱方案,可在无需任何标记和预处理的情况下,即刻从细胞提取物中同时鉴定出这些维生素。由于其简单性,人们可以轻松地将测定延长数小时,而在细胞内 DHA-ASC 转化发挥作用的时间尺度上,这是很难做到的。该方法已针对胰腺癌细胞进行了验证,据我们所知,这是首次针对有核细胞类型进行的研究,可详细追踪葡萄糖转运蛋白依赖性 DHA 摄取以及细胞内 ASC 转化的动力学。所有相关技术中最简单的方法,同时具有以高通量方式提供每种维生素身份的独特能力,这种方法应该为包括大剂量 VC 癌症治疗在内的 VC 相关生理和药物研究提供最实用的选择。